Romatolojik Hastalıkların Nörolojik Manifestasyonları: Juvenil Dermatomiyozit ve Polimiyozitler

Clarissa A. Pilkington, Brain Michael Feldman, Watchareewan Sontichai (2021). Juvenile Dermatomiyositis and Other Inflammatory Muscle Diseases In:Petty RE, Laxer RM, Lindsley CB, Wedderburn L, Fuhlbrigge RC, Mellins ED. (eds) Textbook of pediatric rheumotology Vol:8 Elsevier Health Sciences; Philedelphia

Dalakas MC. Inflammatory muscle diseases. New England Journal of Medicine. 2015 Apr 30;372(18):1734-47.

Tanboon J, Uruha A, Stenzel W, Nishino I. Where are we moving in the classification of idiopathic inflammatory myopathies?. Current opinion in neurology. 2020 Oct 1;33(5):590-603.

Papadopoulou C, McCann LJ. The vasculopathy of juvenile dermatomyositis. Frontiers in pediatrics. 2018 Oct 9;6:284.

Pachman LM, Lipton R, Ramsey‐Goldman R, Shamiyeh E, Abbott K, Mendez EP, Dyer A, Curdy DM, Vogler L, Reed A, Cawkwell G. History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry. Arthritis Care & Research: Official Journal of the American College of Rheumatology. 2005 Apr 15;53(2):166-72.

Papadopoulou C, Chew C, Wilkinson MG, McCann L, Wedderburn LR. Juvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical care. Nature Reviews Rheumatology. 2023 Jun;19(6):343-62.

Mamyrova G, O'Hanlon TP, Monroe JB, Carrick DM, Malley JD, Adams S, Reed AM, Shamim EA, James‐Newton L, Miller FW, Rider LG. Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasians. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 2006 Dec;54(12):3979-87.

Mamyrova G, O'Hanlon TP, Sillers L, Malley K, James‐Newton L, Parks CG, Cooper GS, Pandey JP, Miller FW, Rider LG. Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 2008 Dec;58(12):3941-50.

Takaoka A, Yanai H. Interferon signalling network in innate defence. Cellular microbiology. 2006 Jun;8(6):907-22.

Feldman BM, Rider LG, Reed AM, Pachman LM. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. The Lancet. 2008 Jun 28;371(9631):2201-1

Nagaraju K, Casciola‐Rosen L, Lundberg I, Rawat R, Cutting S, Thapliyal R, Chang J, Dwivedi S, Mitsak M, Chen YW, Plotz P. Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis & Rheumatism. 2005 Jun;52(6):1824-35.

Papadopoulou C, McCann LJ. The vasculopathy of juvenile dermatomyositis. Frontiers in pediatrics. 2018 Oct 9;6:284.

Oh TH, Brumfield KA, Hoskin TL, Stolp KA, Murray JA, Basford JR. Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients. InMayo Clinic Proceedings 2007 Apr 1 (Vol. 82, No. 4, pp. 441-447). Elsevier.

Selva-O'Callaghan A, Pinal-Fernandez I, Trallero-Araguás E, Milisenda JC, Grau-Junyent JM, Mammen AL. Classification and management of adult inflammatory myopathies. The Lancet Neurology. 2018 Sep 1;17(9):816-28.

Ernste FC, Reed AM. Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations. InMayo Clinic Proceedings 2013 Jan 1 (Vol. 88, No. 1, pp. 83-105). Elsevier.

Ufuk İlgen, Hakan Emmungil (2023). İdiopatik Enflamatuar Miyopatiler. Bünyamin Kısacık, Cemal Bes, Süleyman Serdar Koca, Özgür Kasapçopur. (edi) Klinik Romatoloji Vol: 3 Ema Tıp Kitabevi; İstanbul.

Okong’o LO, Esser M, Wilmshurst J, Scott C. Characteristics and outcome of children with juvenile dermatomyositis in Cape Town: a cross-sectional study. Pediatric Rheumatology. 2016 Dec;14:1-8.

Ramanan AV, Sawhney S, Murray KJ. Central nervous system complications in two cases of juvenile onset dermatomyositis. Rheumatology. 2001 Nov 1;40(11):1293-8.

Enders FB, Bader-Meunier B, Baildam E, Constantin T, Dolezalova P, Feldman BM, Lahdenne P, Magnusson B, Nistala K, Ozen S, Pilkington C. Consensus-based recommendations for the management of juvenile dermatomyositis. Annals of the rheumatic diseases. 2017 Feb 1;76(2):329-40.

Li D, Tansley SL. Juvenile dermatomyositis—clinical phenotypes. Current rheumatology reports. 2019 Dec;21:1-7.

Tanboon J, Nishino I. Classification of idiopathic inflammatory myopathies: pathology perspectives. Current Opinion in Neurology. 2019 Oct 1;32(5):704-14.

Schmidt J. Current classification and management of inflammatory myopathies. Journal of neuromuscular diseases. 2018 Jan 1;5(2):109-29.

Bohan A. Polymyositis and dermatomyositis (first of twoparts). N Engl j Med. 1975;292:344.

Bohan A. Polymyositis and dermatomyositis (second of two parts). N Engl j Med. 1975;292:403-7.

Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, De Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis & rheumatology. 2017 Dec;69(12):2271-82.

Guseinova D, Consolaro A, Trail L, Ferrari C, Pistorio A, Ruperto N, Buoncompagni A, Pilkington C, Maillard S, Oliveira SK, Sztajnbok F. Comparison of clinical features and drug therapies among European and Latin American patients with juvenile dermatomyositis. Clinical and experimental rheumatology. 2011 Jan 1;29(1):117-24.

Robinson AB, Hoeltzel MF, Wahezi DM, Becker ML, Kessler EA, Schmeling H, Carrasco R, Huber AM, Feldman BM, Reed AM, Juvenile Myositis CARRA Subgroup, for the CARRA Registry Investigators. Clinical characteristics of children with juvenile dermatomyositis: the Childhood Arthritis and Rheumatology Research Alliance Registry. Arthritis care & research. 2014 Mar;66(3):404-10.

Al-Mayouf SM, AlMutiari N, Muzaffer M, Shehata R, Al-Wahadneh A, Abdwani R, Al-Abrawi S, Abu-Shukair M, El-Habahbeh Z, Alsonbul A. Phenotypic characteristics and outcome of juvenile dermatomyositis in Arab children. Rheumatology international. 2017 Sep;37:1513-7.

Paganoni S, Amato A. Electrodiagnostic evaluation of myopathies. Physical medicine and rehabilitation clinics of North America. 2013 Feb;24(1):193.

Senécal JL, Raynauld JP, Troyanov Y. A new classification of adult autoimmune myositis. Arthritis & Rheumatology. 2017 May;69(5):878-84.

Dalakas MC. Muscle biopsy findings in inflammatory myopathies. Rheumatic Disease Clinics. 2002 Nov 1;28(4):779-98.

Shah M, Mamyrova G, Targoff IN, Huber AM, Malley JD, Rice MM, Miller FW, Rider LG, with the Childhood Myositis Heterogeneity Collaborative Study Group. The clinical phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine. 2013 Jan 1;92(1):25-41.

Senator H. Ueber acute polymyositis und neuromyositis1. DMW-Deutsche Medizinische Wochenschrift. 1893 Sep;19(39):933-6.

Park CK, Yoo SJ, Yoo IS, Kim J, Shim SC, Kang SW. Neuromyositis: a rare extramuscular manifestation of dermatomyositis. Journal of Rheumatic Diseases. 2019 Jul 1;26(3):211-8.

Onder H, GökcemYıldız F, Temucin ÇM. Neuromyositis: Clinical and electrophysiological study of 8 cases. Journal of Medicine and Medical Science. 2015;4(7):347-50.

Cojocaru IM, Socoliuc GA, Sapira V, Bastian AL, Alexianu M, Moldovan M. Dermatomyositis and polyradiculoneuritis, a rare association. Rom J Intern Med. 2011 Jan 1;49:217-.

Nguyen TP, Bangert C, Biliciler S, Athar P, Sheikh K. Dermatomyositis-associated sensory neuropathy: a unifying pathogenic hypothesis. Journal of Clinical Neuromuscular Disease. 2014 Sep 1;16(1):7-11.

Nomura M, Watanabe T, Mikami H, Ishikawa H, Yasui K, Yamazaki T, Irie T, Suzuki M, Ono S. Adult dermatomyositis with severe polyneuropathy: does neuromyositis exist?. Neurological Sciences. 2010 Jun;31:373-6.

Costa IP, Pradebon EP, Campos JV, Melo FS, Tavares FM. Polymyositis associated with lymphocytic arteritis of the central nervous system. Revista Brasileira de Reumatologia. 2010;50:90-5.

Souza FH, Araújo DB, Vilela VS, Bezerra MC, Simões RS, Bernardo WM, Miossi R, Cunha BM, Shinjo SK. Guidelines of the Brazilian Society of Rheumatology for the treatment of systemic autoimmune myopathies. Advances in Rheumatology. 2019 Jul 29;59:6.

Joffe MM, Love LA, Leff RL, Fraser DD, Targoff IN, Hicks JE, Plotz PH, Miller FW. Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy. The American journal of medicine. 1993 Apr 1;94(4):379-87.

Oddis CV, Reed AM, Aggarwal R, Rider LG, Ascherman DP, Levesque MC, Barohn RJ, Feldman BM, Harris‐Love MO, Koontz DC, Fertig N. Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo‐phase trial. Arthritis & Rheumatism. 2013 Feb;65(2):314-24.

Rider LG, Lindsley CB, Cassidy JT. Juvenile dermatomyositis. Textbook of paediatric rheumatology, 6th edition. Saunders Elsevier. 2010 Oct 15:375-413.